Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: GlobeNewswire
MIAMI, June 28, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test, with defined coverage criteria. Under the LCD, Medicare will reimburse the test for patients who meet the defined criteria. The full text of the updated LCD can be found here. The 4Kscore® test is a blood test used by health care professionals to assess a man’s risk of having aggressive prostate cancer after an abnormal prostate specific antigen (PSA) test result. OPKO has offered the 4Kscore® test since 2014 in the U.S., Europe, and elsewhere. The 4Kscore® test has been included in the National Comprehensive Cancer Network Guidelines® (NCCN) since 2015, and European Association of Urology Prostate Cancer Guidelines since 2016. Novitas serves as the Medicare Administrative Contractor for a jurisdiction that includes New Jersey, where OPKO’s BioReference Laboratories, Inc. is l
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024GlobeNewswire
- GeneDx CEO on q3 earnings beat, genetic testing and pediatric health [CNBC]CNBC
- GeneDx climbs after profitability milestone in Q3 [Seeking Alpha]Seeking Alpha
- GeneDx climbs after profitability milestone in Q3 [Seeking Alpha]Seeking Alpha
OPK
Earnings
- 8/7/24 - Beat
OPK
Sec Filings
- 11/4/24 - Form SC
- 9/27/24 - Form 4
- 9/27/24 - Form 4/A
- OPK's page on the SEC website